Treatment of the symptoms of schizophrenia: A meta-analysis comparing risperidone with other antipsychotics

被引：0
|
作者：
Lemmens, P [1 ]
Van Baelen, B [1 ]
Brecher, M [1 ]
机构：
[1] Janssen Res Fdn, B-2340 Beerse, Belgium
来源：
SCHIZOPHRENIA RESEARCH | 1998年 / 29卷 / 1-2期
关键词：
D O I：
10.1016/S0920-9964(97)88671-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [21] A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation
    Satterthwaite, Theodore D.
    Wolf, Daniel H.
    Rosenheck, Robert A.
    Gur, Raquel E.
    Caroff, Stanley N.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (12) : 1869 - 1879
  • [22] A comparison of olanzapine versus risperidone for the treatment of schizophrenia: a meta-analysis of randomised clinical trials
    Mudge, MAC
    Davey, PJ
    Coleman, KA
    Montgomery, W
    Croker, VS
    Mullen, K
    Castle, DJ
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2005, 9 (01) : 3 - 15
  • [23] Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other
    Fleischhacker, WW
    Widschwendter, CG
    CURRENT OPINION IN PSYCHIATRY, 2006, 19 (02) : 128 - 134
  • [24] BENEFITS AND HARMS OF ANTIPSYCHOTICS IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hagi, Katsuhiko
    Nosaka, Tadashi
    Pikalov, Andrei
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S242 - S242
  • [25] A NETWORK META-ANALYSIS TO COMPARE THE EFFICACY AND SAFETY OF ANTIPSYCHOTICS AS MAINTENANCE TREATMENT FOR PATIENTS WITH SCHIZOPHRENIA
    Millier, A.
    Zineddine, O.
    Zhou, J.
    Aballea, S.
    Taieb, V
    Toumi, M.
    VALUE IN HEALTH, 2017, 20 (09) : A709 - A709
  • [26] Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia A Network Meta-analysis
    Samara, Myrto T.
    Dold, Markus
    Gianatsi, Myrsini
    Nikolakopoulou, Adriani
    Helfer, Bartosz
    Salanti, Georgia
    Leucht, Stefan
    JAMA PSYCHIATRY, 2016, 73 (03) : 199 - 210
  • [27] Benefits and harms of antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis
    Hagi, K.
    Nosaka, T.
    Pikalov, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S79 - S80
  • [28] A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia
    Dong, Shimeng
    Schneider-Thoma, Johannes
    Bighelli, Irene
    Siafis, Spyridon
    Wang, Dongfang
    Burschinski, Angelika
    Schestag, Kristina
    Samara, Myrto
    Leucht, Stefan
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2024, 274 (04) : 917 - 928
  • [29] Benefits and Harms of Antipsychotics in the Treatment of Children and Adolescents With Schizophrenia: A Systematic Review and Meta-Analysis
    Hagi, Katsuhiko
    Nosaka, Tadashi
    Pikalov, Andrei
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S369 - S369
  • [30] Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
    Kishi, Taro
    Ikuta, Toshikazu
    Matsunaga, Shinji
    Matsuda, Yuki
    Oya, Kazuto
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 1281 - 1301
12345